The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 20 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 18 Jun 2012 Planned end date changed from 1 Jul 2011 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 26 Jul 2010 Planned end date changed from 1 Mar 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.